Authors Raj Desai and Steven Smith evaluated data for patients with stable hypertension and depression to determine whether the initiation of serotonin norepinephrine reuptake inhibitors had a similar risk of antihypertensive treatment intensification and major adverse cardiovascular events compared to initiation of SSRIs. The full text manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2686.